Dear All,
Not entirely sure from which POV the OP is querying, eg ethical / liability ?
Seems unlikely (to me) that a Regulatory (
haccp) inspection would condone an “
intentionally (?)” generated significant risk of allergen cross-contamination of a hitherto uncontaminated product with a harmful (albeit to a restricted consumer group) contaminant. However I’m unsure what minimum corrective actions from the typical range of options would be demanded. Mere requirement of relevant labeling in such a scenario seems improbable if “practical” options do exist. But ....?
Additionally, as per Marshenkos’s useful attachment (MA), the legal situation regarding allergen labeling also seems to be a minefield, arguably favoring the manufacturer (?)
One recent discussion (2013) I found on the liability aspect was this unofficial article –
m1 - why so many food label disclaimers.pdf 116.15KB
41 downloadsAn extremely detailed, but nonetheless very readable legal survey of the (allergen) liability situation up to 2011 is attached.
m2 - Food allergen law, FDA regulated products.pdf 159.82KB
41 downloadsIf m1, m2 are currently accurate, their content appears to indicate that some of the “myths” listed in the MA document are actually not so far from reality.
Rgds / Charles.C
PS – Here is another very informative 2006 FDA report (ie covering pre / post FALCPA 2004) on allergen consumer studies / inspections / utilized corrective practices / effectiveness of labeling, etc. The report included some chocolate processing operations but does not mention, I think, how many incorporated line corrective actions for
unintentional cross-contamination.
m3 - FDA, 2006, report on FALCPA to Committees.pdf 1.72MB
33 downloads